Table 2.

List of annotated metabolites identified with CEU mass mediator for exometabolome. Metabolites written in italics were characterized by chemical family identification.

Treatments	m/z	Adducts	Formula	Δm/z (ppm)	Compound
PA + T & PA	836.6165	[M+H]+			Phosphatidylcholine
	835.5348	[M-H]-			Glycerophospholipids
	802.5609	[M-H]-			Glycerophosphoserines
	466.2932	[M-H]-	C22H46NO7P	2	PE(17:1(9Z)/0:0)/PC(14:1(9Z)/0:0)
	381.3737	[M-H]-	C25H50O2	0	Pentacosenoic acid/Mycolipenic acid (C25)
	405.3214	[M-H]-	C22H44O6	1	Ventosic acid
	730.57	[M-H]-			Phosphoethanolamin/Glycerophosphocholines
	842.5916	[M-H]-			Glycerophosphoserines
	572.4818/596.528	[M+Cl]- _[M+HAc-H]-	C34H67NO3	1	Ceramide d34:1;
PA + T & T	354.3014	[M-H]-	C21H41NO3	0	N-palmitoyl proline/N-oleoyl alanine
	547.3674	[M+H]+	C32H50O7	8	16-Glutaryloxy-1alpha,25-dihydroxyvitamin D3/16-Glutaryloxy-1alpha,25-dihydroxy-20-epivitamin D3
	866.5909	[M+HAc-H]-	C48H84NO10P	0	PC 38:5; A
	628.3619	[M+HAc-H]-	C30H52NO7P		LPC 22:5;
	398.3272	[M+H]+	C23H43NO4	2	O-palmitoleoylcarnitine/trans-Hexadec-2-enoyl carnitine
	604.3614	[M+HAc-H]-			LPC 20:3;
PA + T & PA & T	859.6912	[M+HAc-H]-			SM d41:1;
	307.2637	[M-H]-	C20H36O2	2	FA 20:2; (eicosadienoic acid)
	787.6146	[M+H]+			Glycerophosphates
	800.5814	[M+HAc-H]-			PC p-34:2; or PC o-34:3;
	811.6775	[M-H]-			Triradylglycerols
	715.5757	[M-H]-			Ceramide phosphoethanolamines
	814.5593	[M-H]-			Glycerophosphoserines
	407.3524	[M-H]-	C26H48O3	2	3,4-Dimethyl-5-pentyl-2-furanpentadecanoic acid
Complete	407.3532	[M-H]-	C26H48O3	2	3,4-Dimethyl-5-pentyl-2-furanpentadecanoic acid
	407.3524	[M-H]-	C26H48O3	2	3,4-Dimethyl-5-pentyl-2-furanpentadecanoic acid
	329.2489	[M-H]-	C22H34O2	1	FA 22:5;
	538.351	[M-H]-			Glycerophosphocholines/Glycerophosphoserines
	808.5882	[M+H]+	C46H82NO8P	4	PC 38:5; B
	537.4896	[M-H]-			Fatty esters
	376.3969	[M+H-H2O]+	C27H39D7O	5	1_Cholesterol d7 iSTD
	269.2489	[M-H]-	C17H34O2	1	FA 17:0; (margaric acid)